- Home
- ABOS vs SOL Comparison
ABOS vs SOL Comparison
Compare ABOS & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- SOL
- Stock Information
- Founded
- ABOS 1996
- SOL 2005
- Country
- ABOS United States
- SOL United States
- Employees
- ABOS N/A
- SOL N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- ABOS Health Care
- SOL Technology
- Exchange
- ABOS Nasdaq
- SOL Nasdaq
- Market Cap
- ABOS 76.9M
- SOL 84.6M
- IPO Year
- ABOS 2021
- SOL 2008
- Fundamental
- Price
- ABOS $1.08
- SOL $1.64
- Analyst Decision
- ABOS Strong Buy
- SOL Buy
- Analyst Count
- ABOS 3
- SOL 3
- Target Price
- ABOS $7.33
- SOL $3.50
- AVG Volume (30 Days)
- ABOS 206.3K
- SOL 646.6K
- Earning Date
- ABOS 03-27-2025
- SOL 03-13-2025
- Dividend Yield
- ABOS N/A
- SOL N/A
- EPS Growth
- ABOS N/A
- SOL N/A
- EPS
- ABOS N/A
- SOL N/A
- Revenue
- ABOS N/A
- SOL $92,067,000.00
- Revenue This Year
- ABOS N/A
- SOL N/A
- Revenue Next Year
- ABOS N/A
- SOL $45.37
- P/E Ratio
- ABOS N/A
- SOL N/A
- Revenue Growth
- ABOS N/A
- SOL N/A
- 52 Week Low
- ABOS $1.05
- SOL $1.04
- 52 Week High
- ABOS $4.06
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- ABOS 34.99
- SOL 51.82
- Support Level
- ABOS $1.14
- SOL $1.53
- Resistance Level
- ABOS $1.28
- SOL $1.73
- Average True Range (ATR)
- ABOS 0.10
- SOL 0.14
- MACD
- ABOS -0.01
- SOL 0.01
- Stochastic Oscillator
- ABOS 6.98
- SOL 78.95
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.